Monthly Newsletter

Agilent Automation Solutions has selected Lab Automation 2011 to launch two new products and a suite of applications advances to help make science easy.

Visitors to Booth 329 will have the chance to see and discuss the new Bravo liquid handling platform for Protein Purification.  The Agilent Bravo for protein purification leverages proprietary AssayMAP microchromatography technology to enable highly parallel and precise antibody purification and titer operations.  Also on public display for the first time will be the new BenchBot Robot - a small footprint, highly flexible robot for benchtop assay automation.

As well as showcasing their new products and applications advances - Agilent Automation Solutions will also host two industry workshops during the conference (January 29th - February 2nd 2011).

The first workshop has been designed to allow attendees to learn about microchromatography and hear how the new Bravo platform is enabling high throughput bioprocess development. Attendees to this workshop will also be able to learn how the Agilent BenchBot robot is revolutionizing the set up and use of small to medium sized assay development workstations, offering unmatched flexibility, throughput, and ease of use.

At the second workshop - Agilent will present an automated solution for Next Generation sequencing library preparation and target enrichment that provides high quality and high throughput sample processing capability combined with maximum walk away time.

For further information or to register for the free industry workshops please click here or contact your local Agilent Automation sales office.

From stand-alone units to fully integrated systems, Agilent Automation Solutions teams key sample preparation and creative walk-away automation approaches with personalized customer service to provide complete solutions for your laboratory.  Combining innovative engineering with high standards of quality, Agilent designs and manufactures high-performance equipment for processes that are revolutionizing pharmaceutical, biotech, and genomic research.